Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from CareCloud ( (CCLD) ) is now available.
CareCloud announced a plan to pay double monthly dividends on its Series B Preferred Stock starting January 2026, aiming to address 14 months of accumulated unpaid dividends from November 2023 through December 2024. This decision reflects CareCloud’s successful financial turnaround, with improved margins and growing recurring revenues, and is designed to fulfill obligations to shareholders without diluting common stock. The double payments are expected to continue until the arrears are fully satisfied, anticipated by the end of the first quarter of 2027.
The most recent analyst rating on (CCLD) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on CareCloud stock, see the CCLD Stock Forecast page.
Spark’s Take on CCLD Stock
According to Spark, TipRanks’ AI Analyst, CCLD is a Neutral.
CareCloud’s overall stock score is driven by a stable financial position and positive earnings call results, highlighting revenue growth and strategic initiatives. However, the negative P/E ratio and lack of dividend yield weigh down the valuation score. Technical indicators show moderate strength, contributing to a balanced outlook.
To see Spark’s full report on CCLD stock, click here.
More about CareCloud
CareCloud is a company that brings innovation to the healthcare industry through its AI and technology-enabled solutions. Their offerings include revenue cycle management, practice management, electronic health records, business intelligence, patient experience management, and digital health. CareCloud serves over 40,000 providers, helping them enhance patient care while reducing administrative burdens and operating costs.
Average Trading Volume: 551,235
Technical Sentiment Signal: Buy
Current Market Cap: $146.9M
Learn more about CCLD stock on TipRanks’ Stock Analysis page.

